What is the best PRN (as needed) medication for a patient with uncontrolled hypertension (HTN) with a blood pressure of 181/85 on lisinopril (angiotensin-converting enzyme inhibitor) 20mg once daily?

Management of Uncontrolled Hypertension on Lisinopril Monotherapy

There is No PRN Medication for Chronic Hypertension Management

PRN (as-needed) medications are not appropriate for chronic hypertension control—you need to add a scheduled antihypertensive agent, not a PRN medication. 1

Your patient has stage 2 hypertension (181/85 mmHg) that is uncontrolled on lisinopril 20mg daily, requiring immediate treatment intensification with scheduled therapy, not PRN dosing. 1

---

Recommended Treatment Algorithm

First Step: Add a Calcium Channel Blocker or Thiazide Diuretic

Add amlodipine 5-10mg once daily OR hydrochlorothiazide 12.5-25mg once daily (or chlorthalidone 12.5-25mg once daily) to the current lisinopril regimen. 1, 2

The 2024 ESC guidelines explicitly recommend combination therapy with an ACE inhibitor plus either a calcium channel blocker or thiazide diuretic for uncontrolled hypertension. 1

Rationale for Each Option:

Calcium Channel Blocker (Amlodipine):

• The combination of ACE inhibitor + calcium channel blocker provides complementary mechanisms: vasodilation plus renin-angiotensin system blockade. 2
• This combination has demonstrated superior blood pressure control compared to either agent alone. 2
• Amlodipine may attenuate peripheral edema if it occurs later. 2

Thiazide Diuretic:

• A diuretic is more effective than a beta-blocker when added to ACE inhibitor therapy for uncontrolled hypertension. 3
• The combination of lisinopril + thiazide diuretic is highly effective, with lisinopril attenuating thiazide-induced hypokalemia. 4
• Chlorthalidone is preferred over hydrochlorothiazide due to its longer duration of action. 2

---

Target Blood Pressure and Monitoring

Target blood pressure is <140/90 mmHg minimum, ideally <130/80 mmHg. 1, 2

• Reassess blood pressure within 2-4 weeks after adding the second agent. 2, 5
• Achieve target blood pressure within 3 months of treatment modification. 2, 5
• Monitor serum potassium and creatinine 2-4 weeks after initiating diuretic therapy to detect hypokalemia or renal function changes. 2

---

If Blood Pressure Remains Uncontrolled on Dual Therapy

Add the Third Agent from the Remaining Class

If blood pressure remains uncontrolled after optimizing dual therapy, add the third agent to achieve guideline-recommended triple therapy: ACE inhibitor + calcium channel blocker + thiazide diuretic. 1, 2

The 2024 ESC guidelines explicitly state that when blood pressure is not controlled with a two-drug combination, increasing to a three-drug combination is recommended, usually a RAS blocker with a dihydropyridine calcium channel blocker and a thiazide/thiazide-like diuretic. 1

---

Resistant Hypertension (If Triple Therapy Fails)

If blood pressure remains uncontrolled despite optimized triple therapy, add spironolactone 25-50mg daily as the preferred fourth-line agent. 1, 2

• The 2024 ESC guidelines specifically recommend low-dose spironolactone for resistant hypertension. 1
• Monitor potassium closely when adding spironolactone to an ACE inhibitor, as hyperkalemia risk is significant. 2
• Alternative fourth-line agents if spironolactone is not tolerated include eplerenone, amiloride, higher-dose thiazide, beta-blocker (bisoprolol), or alpha-blocker (doxazosin). 1

---

Critical Pitfalls to Avoid

Do not use PRN antihypertensive medications for chronic blood pressure control—this is not guideline-recommended and will not achieve adequate 24-hour blood pressure control. 1

Do not add a beta-blocker as the second or third agent unless there are compelling indications (angina, post-MI, heart failure with reduced ejection fraction, or need for heart rate control). 2

Do not combine two RAS blockers (ACE inhibitor plus ARB), as this increases adverse events without additional benefit. 2

Do not delay treatment intensification for stage 2 hypertension—prompt action is required to reduce cardiovascular risk. 2

Do not add a third drug class before optimizing doses of the current two-drug regimen, as this violates guideline-recommended stepwise approaches. 2

---

Lifestyle Modifications to Reinforce

Reinforce sodium restriction to <2g/day, weight management (target BMI 20-25 kg/m²), regular aerobic exercise, and alcohol limitation to <100g/week—these provide additive blood pressure reductions of 10-20 mmHg. 1, 2